Key Points
- Mario Schlosser, an Oscar Health insider, sold 38,835 shares on Dec. 24 at an average price of $15 (about $582,525), trimming his stake by 8.14% and joining prior large sales on Nov. 11 and Dec. 2—indicating a pattern of recent insider selling.
- Oscar Health trades below its 50‑ and 200‑day averages (open $14.50; 50d $16.31, 200d $17.08), has a market cap of $3.84B and an average analyst rating of "Reduce" with a consensus target of $15.57; the company slightly beat EPS estimates last quarter but missed revenue and remains unprofitable.
Oscar Health, Inc. (NYSE:OSCR - Get Free Report) insider Mario Schlosser sold 38,835 shares of the firm's stock in a transaction that occurred on Wednesday, December 24th. The shares were sold at an average price of $15.00, for a total transaction of $582,525.00. Following the completion of the sale, the insider owned 438,348 shares in the company, valued at $6,575,220. The trade was a 8.14% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink.
Mario Schlosser also recently made the following trade(s):
- On Tuesday, December 2nd, Mario Schlosser sold 23,965 shares of Oscar Health stock. The stock was sold at an average price of $16.59, for a total value of $397,579.35.
- On Tuesday, November 11th, Mario Schlosser sold 286,182 shares of Oscar Health stock. The stock was sold at an average price of $15.27, for a total value of $4,369,999.14.
Oscar Health Stock Down 0.2%
OSCR opened at $14.50 on Wednesday. The stock's 50 day moving average price is $16.31 and its 200 day moving average price is $17.08. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.92 and a quick ratio of 0.92. The stock has a market cap of $3.84 billion, a P/E ratio of -12.94 and a beta of 1.88. Oscar Health, Inc. has a 12 month low of $11.20 and a 12 month high of $23.80.
Oscar Health (NYSE:OSCR - Get Free Report) last released its quarterly earnings results on Thursday, November 6th. The company reported ($0.53) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.55) by $0.02. The company had revenue of $2.93 billion during the quarter, compared to analysts' expectations of $3.09 billion. Oscar Health had a negative return on equity of 21.50% and a negative net margin of 2.16%.The company's revenue for the quarter was up 23.2% compared to the same quarter last year. During the same quarter in the prior year, the business posted ($0.22) earnings per share. As a group, research analysts predict that Oscar Health, Inc. will post 0.69 earnings per share for the current year.
Analysts Set New Price Targets
A number of analysts have recently weighed in on the stock. Weiss Ratings reaffirmed a "sell (d)" rating on shares of Oscar Health in a research note on Wednesday, October 8th. Stephens initiated coverage on Oscar Health in a research report on Thursday, December 11th. They issued an "equal weight" rating and a $17.00 target price for the company. Piper Sandler raised Oscar Health from a "neutral" rating to an "overweight" rating and increased their price target for the company from $13.00 to $25.00 in a research note on Tuesday, November 25th. Wall Street Zen cut Oscar Health from a "hold" rating to a "sell" rating in a research report on Saturday, December 6th. Finally, Zacks Research upgraded Oscar Health from a "strong sell" rating to a "hold" rating in a report on Monday, October 13th. One research analyst has rated the stock with a Buy rating, six have given a Hold rating and four have issued a Sell rating to the stock. Based on data from MarketBeat, Oscar Health currently has an average rating of "Reduce" and a consensus target price of $15.57.
Get Our Latest Stock Analysis on Oscar Health
Institutional Inflows and Outflows
Several hedge funds have recently added to or reduced their stakes in OSCR. Vanguard Group Inc. lifted its position in shares of Oscar Health by 2.1% during the 3rd quarter. Vanguard Group Inc. now owns 20,160,399 shares of the company's stock valued at $381,636,000 after acquiring an additional 423,184 shares during the last quarter. Thrive Capital Management LLC raised its position in shares of Oscar Health by 33.4% during the fourth quarter. Thrive Capital Management LLC now owns 6,343,617 shares of the company's stock worth $85,258,000 after purchasing an additional 1,588,395 shares during the period. American Century Companies Inc. lifted its holdings in shares of Oscar Health by 89.0% during the third quarter. American Century Companies Inc. now owns 5,298,340 shares of the company's stock valued at $100,298,000 after purchasing an additional 2,495,691 shares during the last quarter. Dimensional Fund Advisors LP boosted its position in shares of Oscar Health by 0.9% in the 3rd quarter. Dimensional Fund Advisors LP now owns 3,718,765 shares of the company's stock valued at $70,400,000 after purchasing an additional 31,785 shares during the period. Finally, Farallon Capital Management LLC boosted its position in shares of Oscar Health by 146.5% in the 3rd quarter. Farallon Capital Management LLC now owns 3,639,000 shares of the company's stock valued at $68,886,000 after purchasing an additional 2,163,000 shares during the period. Institutional investors and hedge funds own 75.70% of the company's stock.
About Oscar Health
(
Get Free Report)
Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.
The company's primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
